Brighton, MA, United States of America

Irvith M Carvajal

This inventor holds 6 USPTO granted patents and 4 published patent applications and 2 EPO patents. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2012-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Irvith M Carvajal. Retrieved from https://idiyas.com/inventor/irvith-m-carvajal

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 

% Patents Active = 100.0

 

Average Co-Inventor Count = 8.0

ph-index = 4

Forward Citations = 131(Granted Patents)


Location History:

  • Brighton, MA (US) (2012 - 2018)
  • Somerville, MA (US) (2020 - 2022)

Company Filing History:


Years Active: 2012-2022

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Mind of Irvith M Carvajal

Introduction: Irvith M Carvajal, a talented inventor based in Brighton, MA (US), is known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Carvajal's latest patents include a revolutionary smart home device that integrates artificial intelligence for enhanced security and convenience.

Career Highlights: With a career spanning over two decades, Carvajal has consistently pushed the boundaries of technology, with notable achievements in the fields of robotics, renewable energy, and healthcare.

Collaborations: Throughout his career, Carvajal has collaborated with leading tech companies, research institutions, and universities to bring his innovative ideas to life and make a lasting impact on society.

Conclusion: Irvith M Carvajal's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…